InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the ” Minimally Invasive Gastrointestinal Surgical Systems Market – (By Product Type (Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS) (Endoscopes and Endoscopy Systems (Rigid Endoscopes, Flexible Endoscopes, Capsule Endoscopy (Workstations and Data Recorders, Capsules, Others)), Videoscopes, Endoscopy Ultrasound, Therapeutic Energy Devices, Point of Sales), Surgical Robotics (Robotic Systems, Robotic Surgery Instruments and Accessories, Services)), By Surgery (Adrenalectomy, Appendectomy, Bariatric Surgery, Cholecystectomy, Colon & Rectal Surgery, Foregut Surgery, Hernia Repair, Others), By End-User (Specialty Clinics, Hospitals, Ambulatory Surgical Centers)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031.”
According to the latest research by InsightAce Analytic, the Minimally Invasive Gastrointestinal Surgical Systems Market is valued at US$ 5.75 Bn in 2023, and it is expected to reach US$ 9.88 Bn by 2031, with a CAGR of 7.2% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2847
Minimally invasive gastrointestinal (GI) surgical systems utilize advanced technologies—including laparoscopy, endoscopy, and robotic-assisted platforms—to perform procedures through small incisions, thereby reducing tissue trauma and accelerating patient recovery. These systems have gained significant adoption due to their demonstrated clinical efficacy, operational efficiency, and the ability to substantially shorten hospital stays compared to conventional surgical approaches.
Continuous technological innovations have enhanced the precision, safety, and reliability of surgical instruments and robotic platforms, further supporting their integration into contemporary surgical practices.
Healthcare institutions are increasingly investing in minimally invasive GI systems to address rising demand for less invasive procedures and to improve overall patient outcomes. Additionally, patient preference for procedures that minimize pain, lower complication risks, and reduce scarring is contributing to market growth. The convergence of favorable clinical performance and growing patient acceptance is expected to drive sustained expansion of the minimally invasive gastrointestinal surgical systems market in the foreseeable future.
List of Major Players in the Minimally Invasive Gastrointestinal Surgical Systems Market:
- Braun Melsungen AG
- Conmed Corporation
- Karl Storz SE & Co. KG
- Medtronic plc
- Olympus Corporation
- Stryker Corporation
- TransEnterix, Inc.
- Boston Scientific Corporation
- Cook Medical, Inc.
- Richard Wolf GmbH
- Intuitive Surgical, Inc.
- Ambu A/S
- Schölly Fiber Optic GmbH
- Xenocor, Inc.
- Fujifilm Holdings Corporation
- Pentax Medical (Hoya Corporation)
- Smith & Nephew,
- Abbott,
- Applied Biomedical, LLC
- Aesculap, Inc.,
- Johnson & Johnson Services, Inc.,
- Novatract Surgical Inc.,
- REMA Medizintechnik GmbH,
- Teleflex Incorporated,
- Other Prominent Players
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics
Drivers:
The expansion of the minimally invasive gastrointestinal (GI) surgical systems market is principally fueled by ongoing advancements in robotic surgery, laparoscopy, and endoscopic technologies. Growing patient preference for procedures that minimize recovery time, reduce scarring, and enhance clinical outcomes is driving adoption.
Increased awareness of the benefits associated with minimally invasive interventions, coupled with the rising incidence of obesity and GI-related disorders, further supports market growth. Additional factors contributing to expansion include a growing geriatric population, increased utilization in ambulatory surgical centers, favorable reimbursement policies, declining procedural costs, and broader application in oncology and bariatric surgeries. Furthermore, government initiatives aimed at strengthening healthcare infrastructure and incentivizing surgical innovations are expected to bolster market development.
Challenges:
Despite significant growth potential, the market faces several challenges. The technical complexity of procedures, limited availability of trained surgical professionals, and substantial capital investment required for acquiring advanced systems pose notable barriers, particularly in low- and middle-income regions.
Financial constraints may limit patient access to sophisticated surgical interventions, while concerns regarding procedural risks—including bleeding, infection, and other complications—can affect adoption rates. Additionally, shortages of specialized personnel and restricted procedural accessibility in developing regions continue to impede market penetration.
Regional Trends:
North America is anticipated to retain a dominant position in the global minimally invasive GI surgical systems market, supported by a high prevalence of gastrointestinal disorders, rising healthcare expenditures, rapid uptake of advanced surgical technologies, and sustained governmental investment in healthcare infrastructure.
Europe also accounts for a significant share, underpinned by a strong regulatory framework, mature healthcare systems, and a skilled workforce. The presence of leading market players, continuous innovation, and robust clinical adoption further reinforce the region’s competitive advantage and ongoing market growth.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2847
Recent Developments:
- In Nov 2023, Stryker Endoscopy (San Jose, CA) obtained FDA certification for the enhanced Stryker 1788 4K Camera System including Advanced Imaging Modality. The 1788 Platform represents the most recent advancement in the series of Stryker endoscopic camera systems. This is the inaugural update since the launch of the 1688 AIM 4K in 2019 and the seventh generation since the introduction of the original 1088 in 2004. This generation features hardware upgrades, software modifications for light-balancing, and advances in fluorescence imaging capabilities.
Segmentation of Minimally Invasive Gastrointestinal Surgical Systems Market-
By Product Type-
- Conventional Minimally Invasive Gastrointestinal Surgical Systems (MISS)
- Endoscopes and Endoscopy Systems
- Rigid Endoscopes
- Flexible Endoscopes
- Capsule Endoscopy
- Workstations and Data Recorders
- Capsules
- Others
- Videoscopes
- Endoscopy Ultrasound
- Therapeutic Energy Devices
- Point of Sales
- Surgical Robotics
- Robotic Systems
- Robotic Surgery Instruments and Accessories
- Services
- Endoscopes and Endoscopy Systems
By Surgery-
- Adrenalectomy
- Appendectomy
- Bariatric Surgery
- Cholecystectomy
- Colon & Rectal Surgery
- Foregut Surgery
- Hernia Repair
- Others
By End-User-
- Specialty Clinics
- Hospitals
- Ambulatory Surgical Centers
By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: https://www.insightaceanalytic.com/
Tel : +1 607 400-7072
Asia: +91 79 72967118
info@insightaceanalytic.com
